BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18177938)

  • 21. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA; Weiner GJ
    J Immunol Methods; 2005 Sep; 304(1-2):88-99. PubMed ID: 16109421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells: frequency, phenotype and function in healthy cats.
    Vermeulen BL; Devriendt B; Olyslaegers DA; Dedeurwaerder A; Desmarets LM; Grauwet KL; Favoreel HW; Dewerchin HL; Nauwynck HJ
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):69-78. PubMed ID: 22985632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127.
    Vosshenrich CA; García-Ojeda ME; Samson-Villéger SI; Pasqualetto V; Enault L; Richard-Le Goff O; Corcuff E; Guy-Grand D; Rocha B; Cumano A; Rogge L; Ezine S; Di Santo JP
    Nat Immunol; 2006 Nov; 7(11):1217-24. PubMed ID: 17013389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural cytotoxicity in the guinea-pig: the natural killer (NK) cell activity of the Kurloff cell.
    Eremin O; Coombs RR; Ashby J; Plumb D
    Immunology; 1980 Oct; 41(2):367-78. PubMed ID: 7439932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bovine NK cells acquire cytotoxic activity and produce IFN-gamma after stimulation by Mycobacterium bovis BCG- or Babesia bovis-exposed splenic dendritic cells.
    Bastos RG; Johnson WC; Mwangi W; Brown WC; Goff WL
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):302-12. PubMed ID: 18514329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of rhesus macaque natural killer activity against a rhesus-derived target cell line at the single-cell level.
    Andersen H; Rossio JL; Coalter V; Poore B; Martin MP; Carrington M; Lifson JD
    Cell Immunol; 2004; 231(1-2):85-95. PubMed ID: 15919373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
    Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
    Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity.
    Alcón VL; Luther C; Balce D; Takei F
    Eur J Immunol; 2009 Mar; 39(3):826-32. PubMed ID: 19197938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased natural killer-cell mobilization and cytotoxicity during marital conflict.
    Dopp JM; Miller GE; Myers HF; Fahey JL
    Brain Behav Immun; 2000 Mar; 14(1):10-26. PubMed ID: 10729214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and analysis of human natural killer cell subsets.
    Ferlazzo G
    Methods Mol Biol; 2008; 415():197-213. PubMed ID: 18370156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M; Söderberg-Nauclér C; Odeberg J
    Immunobiology; 2009; 214(5):331-41. PubMed ID: 19152985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells.
    Cecchetti S; Spadaro F; Lugini L; Podo F; Ramoni C
    Eur J Immunol; 2007 Oct; 37(10):2912-22. PubMed ID: 17899539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated killer cell activity in lymph nodes.
    Akiyoshi T; Koba F; Tsuji H
    J Clin Lab Immunol; 1987 Feb; 22(2):91-5. PubMed ID: 3496459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells from Peyer's patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria.
    Fink LN; Frøkiaer H
    Scand J Immunol; 2008 Sep; 68(3):270-9. PubMed ID: 18565117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD16
    Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
    Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic characterisation of porcine counterparts of human NK cell populations--implications for pre-clinical studies.
    Krog J; Hokland M; Andersen SK; Tønnesen E
    APMIS Suppl; 2003; (109):133-9. PubMed ID: 12874965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.